Lenzi M - Search Results

1

Evaluation of Cytotoxic and Mutagenic Effects of the Synthetic Cathinones Mexedrone, α-PVP and α-PHP.

Lenzi M, Cocchi V, Gasperini S, Arfè R, Marti M, Hrelia P. Lenzi M, et al. Int J Mol Sci. 2021 Jun 12;22(12):6320. doi: 10.3390/ijms22126320. Int J Mol Sci. 2021. PMID: 34204826 Free PMC article.

2

Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations.

Fimognari C, Nüsse M, Lenzi M, Sciuscio D, Cantelli-Forti G, Hrelia P. Fimognari C, et al. Among authors: lenzi m. Mutat Res. 2006 Oct 10;601(1-2):92-101. doi: 10.1016/j.mrfmmm.2006.06.001. Epub 2006 Jul 14. Mutat Res. 2006. PMID: 16843502

3

Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation.

Fimognari C, Lenzi M, Sciuscio D, Cantelli-Forti G, Hrelia P. Fimognari C, et al. Among authors: lenzi m. Ann N Y Acad Sci. 2007 Jan;1095:62-9. doi: 10.1196/annals.1397.008. Ann N Y Acad Sci. 2007. PMID: 17404018

4

Cell-cycle specificity of sulforaphane-mediated apoptosis in Jurkat T-leukemia cells.

Fimognari C, Lenzi M, Sciuscio D, Cantelli-Forti G, Hrelia P. Fimognari C, et al. Among authors: lenzi m. In Vivo. 2007 Mar-Apr;21(2):377-80. In Vivo. 2007. PMID: 17436591 Free article.

5

Chemoprevention of cancer by isothiocyanates and anthocyanins: mechanisms of action and structure-activity relationship.

Fimognari C, Lenzi M, Hrelia P. Fimognari C, et al. Among authors: lenzi m. Curr Med Chem. 2008;15(5):440-7. doi: 10.2174/092986708783503168. Curr Med Chem. 2008. PMID: 18288999 Review.

6

Induction of differentiation in human promyelocytic cells by the isothiocyanate sulforaphane.

Fimognari C, Lenzi M, Cantelli-Forti G, Hrelia P. Fimognari C, et al. Among authors: lenzi m. In Vivo. 2008 May-Jun;22(3):317-20. In Vivo. 2008. PMID: 18610742 Free article.

7

Interaction of the isothiocyanate sulforaphane with drug disposition and metabolism: pharmacological and toxicological implications.

Fimognari C, Lenzi M, Hrelia P. Fimognari C, et al. Among authors: lenzi m. Curr Drug Metab. 2008 Sep;9(7):668-78. doi: 10.2174/138920008785821675. Curr Drug Metab. 2008. PMID: 18781917 Review.

8

RNA as a new target for toxic and protective agents.

Fimognari C, Sestili P, Lenzi M, Bucchini A, Cantelli-Forti G, Hrelia P. Fimognari C, et al. Among authors: lenzi m. Mutat Res. 2008 Dec 15;648(1-2):15-22. doi: 10.1016/j.mrfmmm.2008.09.003. Epub 2008 Sep 18. Mutat Res. 2008. PMID: 18840453

9

Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells.

Fimognari C, Lenzi M, Hrelia P. Fimognari C, et al. Among authors: lenzi m. Environ Mol Mutagen. 2009 Apr;50(3):171-89. doi: 10.1002/em.20447. Environ Mol Mutagen. 2009. PMID: 19170195 Review.

10

Protective effect of creatine against RNA damage.

Fimognari C, Sestili P, Lenzi M, Cantelli-Forti G, Hrelia P. Fimognari C, et al. Among authors: lenzi m. Mutat Res. 2009 Nov 2;670(1-2):59-67. doi: 10.1016/j.mrfmmm.2009.07.005. Epub 2009 Jul 23. Mutat Res. 2009. PMID: 19631670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters